Net profit of Anuh Pharma rose 892.22% to Rs 8.93 crore in the quarter ended March 2022 as against Rs 0.90 crore during the previous quarter ended March 2021. Sales rose 32.75% to Rs 128.97 crore in the quarter ended March 2022 as against Rs 97.15 crore during the previous quarter ended March 2021. For the full year,net profit rose 7.45% to Rs 30.56 crore in the year ended March 2022 as against Rs 28.44 crore during the previous year ended March 2021. Sales rose 12.66% to Rs 486.65 crore in the year ended March 2022 as against Rs 431.96 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 128.97 | 97.15 | 33 | 486.65 | 431.96 | 13 |
OPM % | 10.75 | 4.19 | – | 9.63 | 10.32 | – |
PBDT | 15.08 | 5.48 | 175 | 51.09 | 53.64 | -5 |
PBT | 12.07 | 1.67 | 623 | 39.13 | 38.56 | 1 |
NP | 8.93 | 0.90 | 892 | 30.56 | 28.44 | 7 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.